← back to search
Andrew M. Hau
Mabvax Therapeutics (United States) · US
Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, HER2/EGFR in Cancer Research, PI3K/AKT/mTOR signaling in cancer, and Marine Sponges and Natural Products.
h-index
15
citations
696
works
34
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Mammalian Target of Rapamycin Complex 2 (mTORC2) Is a Critical Determinant of Bladder Cancer Invasion
PLoS ONE
2013
cited by
63
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Donna E. Hansel
· The University of Texas MD Anderson Cancer Center
1
papers (2013–2013)
—
·
1
papers (2013–2013)
Thomas Egelhoff
· Case Western Reserve University
1
papers (2013–2013)
Elisabetta Mantuano
· Link Campus University
1
papers (2013–2013)
Sounak Gupta
· Mayo Clinic
1
papers (2013–2013)
Jordan R. Beach
· National Heart Lung and Blood Institute
1
papers (2013–2013)
Steven L. Gonias
· University of California San Diego
1
papers (2013–2013)